Shopping Cart
Remove All
Your shopping cart is currently empty
BIEGi-1 is a potent and selective EGFR dimerization inhibitor that effectively blocks EGFR-catalyzed nucleotide exchange and disrupts the EGFR-Rheb interaction. It strongly inhibits EGFR kinase activity and mTORC1 signaling in EGFR-mutant cancer cells. BIEGi-1 exhibits significant antiproliferative effects, with an IC50 of 17 nM against [PC9] and an IC50 of 20 nM against [HCC827].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | BIEGi-1 is a potent and selective EGFR dimerization inhibitor that effectively blocks EGFR-catalyzed nucleotide exchange and disrupts the EGFR-Rheb interaction. It strongly inhibits EGFR kinase activity and mTORC1 signaling in EGFR-mutant cancer cells. BIEGi-1 exhibits significant antiproliferative effects, with an IC50 of 17 nM against [PC9] and an IC50 of 20 nM against [HCC827]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.